Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Sep 12, 2025

Accession no.
0001628280-25-041987
Filed
Sep 12, 2025
Trade date
Aug 1-29, 2025
Filing delay
42 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $861.57. It was filed 42 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2025Common StockPPurchaseAcquired+13$3.44+$44.7243,689Direct
Aug 4, 2025Common StockPPurchaseAcquired+13$4.01+$52.1343,702Direct
Aug 5, 2025Common StockPPurchaseAcquired+13$3.92+$50.9643,715Direct
Aug 6, 2025Common StockPPurchaseAcquired+13$3.34+$43.4243,728Direct
Aug 7, 2025Common StockPPurchaseAcquired+13$3.14+$40.8243,741Direct
Aug 8, 2025Common StockPPurchaseAcquired+13$3.39+$44.0743,754Direct
Aug 11, 2025Common StockPPurchaseAcquired+13$2.87+$37.3143,767Direct
Aug 12, 2025Common StockPPurchaseAcquired+13$2.91+$37.8343,780Direct
Aug 13, 2025Common StockPPurchaseAcquired+13$2.94+$38.2243,793Direct
Aug 14, 2025Common StockPPurchaseAcquired+13$2.84+$36.9243,806Direct
Aug 15, 2025Common StockPPurchaseAcquired+13$3.02+$39.2643,819Direct
Aug 18, 2025Common StockPPurchaseAcquired+13$3.11+$40.4343,832Direct
Aug 19, 2025Common StockPPurchaseAcquired+13$3.23+$41.9943,845Direct
Aug 20, 2025Common StockPPurchaseAcquired+2$3.15+$6.343,847Direct
Aug 21, 2025Common StockPPurchaseAcquired+13$3.25+$42.2543,860Direct
Aug 22, 2025Common StockPPurchaseAcquired+13$3.31+$43.0343,873Direct
Aug 25, 2025Common StockPPurchaseAcquired+13$3.32+$43.1643,886Direct
Aug 26, 2025Common StockPPurchaseAcquired+13$3.39+$44.0743,899Direct
Aug 27, 2025Common StockPPurchaseAcquired+13$3.44+$44.7243,912Direct
Aug 28, 2025Common StockPPurchaseAcquired+13$3.47+$45.1143,925Direct
Aug 29, 2025Common StockPPurchaseAcquired+13$3.45+$44.8543,938Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)